QUESTIONS TO
ASK ABOUT ONCOLYTIC VIRUS THERAPY
The consultation that produces useful information about T-VEC requires specific questions designed to require specific a
Before Consenting to T-VEC
These questions require specific numbers and specific criteria. Specific questions produce specific answers.
Staging-Specific Response Rate
What is the durable response rate for patients at my specific disease stage β IIIB, IVM1a, IVM1b, or IVM1c β not the overall 16.3% trial average?
Lesion Selection and Continuation Criteria
Which specific lesions will be injected, and what criteria guide the decision to continue or stop treatment?
Expected Response Pattern
What does the expected response pattern look like β specifically, will lesion enlargement happen before regression?
Household Precautions
What specific household precautions apply based on who lives in my home?
Before Choosing Monotherapy vs Combination
Checkpoint Inhibitor History
Am I checkpoint inhibitor-naive? Does that change the recommendation for monotherapy versus combination?
Cold Tumor Biology Assessment
Is there evidence my tumour is immunologically cold β low CD8+ infiltration, PD-L1 negative β that would make the combination approach specifically indicated?
Combination Toxicity
What toxicity does the checkpoint inhibitor addition bring, and how is it monitored?
About This Oncologist's T-VEC Experience
Personal Volume
How many T-VEC patients have you personally treated? Have you managed the lesion enlargement response pattern before?
Referral If Needed
If a more experienced centre would serve this case better β where would you refer, and would you support that referral?
Frequently Asked Questions
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination β travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Want Expert Review of Your T-VEC Treatment Plan?
CancerFax connects patients with specialist oncologists experienced in T-VEC and oncolytic virus combination therapy for independent review.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.